Abits
ABTS
BIT Mining
BTCM
Intchains Group
ICG
Digihost Technology
DGHI
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
NLSP NLS Pharmaceutics
- 1.5800
- +0.0300+1.94%
Trading Mar 18 10:03 ET
6.41MMarket Cap-0.23P/E (TTM)
1.6087High1.5200Low15.92KVolume1.5600Open1.5500Pre Close24.87KTurnover0.50%Turnover RatioLossP/E (Static)4.06MShares18.388052wk High-0.69P/B5.04MFloat Cap1.470052wk Low--Dividend TTM3.19MShs Float294.0000Historical High--Div YieldTTM5.72%Amplitude1.4700Historical Low1.5620Avg Price1Lot Size
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
NLS Pharmaceutics Stock Forum
NLS Pharmaceutics CEO Issues Letter to Shareholders
NLS Pharmaceutics Announces New Preclinical Data for AEX-2, Expanding the Therapeutic Potential of its Non-Sulfonamide Dual Orexin Receptor Agonist Platform
Thursday, 27th February at 7:00 am
ZÜRICH, Switzerland, Feb. 27, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), in collaboration with Aexon Labs Inc. ("Aexon Labs"), is pleased to announce new preclinical findings on AEX-2, reinforcing its potential as a f...
Can NLS Pharmaceutics' Orexin Agonist Treat More Than Just Sleep Disorders? New Data Says Yes
Could This Stem Cell Therapy Eliminate Immunosuppression for Type 1 Diabetes Patients?
Kadimastem and Itolerance Successfully Complete Pre-Ind Meeting With the FDA for Its Type 1 Diabetes Treatment
Kadimastem and iTolerance Successfully Complete Pre-IND Meeting with the FDA for its Type 1 Diabetes Treatment
Tuesday, 25th February at 9:05 am
Companies Advance Collaborative Clinical Development of iTOL-102: A Potential Cure for Diabetes Without the Need for Chronic Life-long Immune Suppression
ZURICH and NESS ZIONA, Israel, Feb. 25, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) ("NLS") and Kadimastem Ltd. (TASE: KDST) ("Kadimastem"), a clinical-s...
$NLS Pharmaceutics (NLSP.US)$ Needs to run to 4.00 to make shares available. It is at where it moves sideways for 2-3 days then breaksout. Being patient will pay off.
$Transcode Therapeutics (RNAZ.US)$ Friday looks good for this to run again. They can dip it a little more but not much. Buying in between 10.00-10.30 will give a 70% profit when it tries to breakout over the 16.84 price.
Best to hold off on Chinese stocks until next month. I don...
No comment yet